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Multifaceted Contributions of
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Bjo¨rn E. Clausen1 and Stephan Grabbe2
Recent findings have established that epidermal Langerhans cells (LCs) promote
polyaromatic hydrocarbon (PAH)–induced carcinogenesis independent of their
immunological properties by generating mutagenic PAH metabolites. In this issue,
Girardi and colleagues (2014) extend their previous work and demonstrate that
this mutagenic metabolism of LCs is indeed mediated by preferential expression
of the cytochrome P450 enzyme CYP1B1, but that LCs cells exert their pro-
carcinogenic effects also independently of CYP1B1.
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Non-melanoma skin cancers are induced
by UVR and mutagenic polyaromatic
hydrocarbons
With an incidence of 100–300 cases per
one million inhabitants per year and 2.1
million patients treated for non-mela-
noma skin cancer in the United States
alone (2006), non-melanoma skin can-
cer is the most common human tumor.
However, because of early detection
and low rate of metastasizing tumors,
it accounts for o0.1% of cancer deaths
(http://www.cancer.gov/cancertopics/
pdq). Approximately 20–25% of non-
melanoma skin cancers are squamous
cell carcinomas (SCCs) of the skin. The
vast majority of these are induced by
UVR as the dominant carcinogen, but
human SCC can also be triggered by
chemical substances such as polyaro-
matic hydrocarbons (PAHs) and arsenic,
which are readily absorbed by skin cells
following topical or systemic exposure.
Although the relevance of purely che-
mically induced SCC has decreased
because of increased risk awareness
and occupational health regulations in
developed countries, there is a growing
debate about a co-carcinogenic rele-
vance of PAHs from tobacco smoke or
automobile exhaust fumes to UVR-
induced skin cancer.
Langerhans cells can trigger cutaneous
carcinogenesis independent of adaptive
immunity via mutagenic metabolism of
PAHs
Skin cancer, and SCC in particular, is
under tight control of the body’s anti-
tumor defense mechanisms. Among
these, DNA repair mechanisms and the
immune system are the most relevant,
as patients with defective DNA repair
(such as in xeroderma pigmentosum) or
patients who have a compromised
immune system (such as immunosup-
pressed organ transplant recipients)
have greatly enhanced SCC incidences
and SCCs are also more likely to metas-
tasize in these patients. In this issue,
Lewis et al., (2014) extend their pre-
viously published observation that epi-
dermal Langerhans cell (LC)-deficient
mice are resistant to chemical carcino-
genesis initiated by the model PAH 7,12-
dimethylbenz[a]anthracene (DMBA) and
subsequent treatment with the tumor
‘‘promoter’’ 12-O-tetradecanoylphorbol
13-acetate (TPA; Modi et al., 2012). As
expected, repopulation of LC-deficient
mice using wild-type fetal liver LC pre-
cursors restores DMBA-mediated tumor
susceptibility. In contrast, reconstitution
of LCs with precursors from CYP1B1 /
mice failed to reinstate tumor develop-
ment in DMBA/TPA-treated skin. The
cytochrome p450 (CYP) enzyme
CYP1B1 metabolizes DMBA to muta-
genic DMBA-t-3,4-diol that is then
further transformed to the highly
mutagenic DMBA-t-3,4-diol-1,2-epoxide
within adjacent keratinocytes (Modi
et al., 2012). These data are in agree-
ment with the high ratio of CYP1B1:
CYP1A1 in human LCs that may
facilitate the mutagenic metabolism
of PAHs, which in turn cause DNA
damage and trigger carcinogenesis in
keratinocytes. It is presently not known
how LCs transfer these mutagenic
metabolites to the keratinocytes and
why the latter are not protected from
mutations as they express markedly
elevated levels of CYP1A1, which is
supposed to be detoxifying. Intrigu-
ingly, in DMBA-exposed mice only
B1% of LCs exhibited any DNA
damage, indicating that the cells effi-
ciently protect themselves against their
own genotoxicity, while damaging the
neighboring keratinocytes. The effective
nuclear exclusion of DMBA within LCs
may represent one protective cellular
process whose molecular mechanism
remains to be determined (Figure 1
and Table 1).
DNA-damaged LCs facilitate UVR-
induced photocarcinogenesis through
induction of regulatory T cells
Despite the widespread presence of
PAHs in the environment, the vast
majority of skin cancers are induced
by UVR. The key event in photocarci-
nogenesis is the induction of DNA
damage, in particular, cyclobutane
pyrimidine dimers and 6-4 photopro-
ducts (Jantschitsch et al., 2012). Next
to its direct mutagenic effect, UVR-
induced DNA lesions have been
recognized as the major molecular
trigger of UVR to suppress the immune
system (Schwarz and Schwarz, 2011).
Using the model of UVR suppression of
See related article on pg 1405
1Institute for Molecular Medicine, University Medical Center of The Johannes Gutenberg-University Mainz,
Mainz, Germany and 2Department of Dermatology, University Medical Center of The Johannes
Gutenberg-University Mainz, Mainz, Germany
Correspondence: Bjo¨rn E. Clausen, Institute for Molecular Medicine, University Medical Center of The
Johannes Gutenberg-University Mainz, Obere Zahlbacher Strasse 67, Mainz 55131, Germany.
E-mail: bclausen@uni-mainz.de or Stephan Grabbe, Department of Dermatology, University Medical
Center of The Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, Mainz 55131, Germany.
E-mail: stephan.grabbe@unimedizin-mainz.de
COMMENTARY
1218 Journal of Investigative Dermatology (2015), Volume 135
contact hypersensitivity (CHS) reactions
following the topical application of
potent contact allergens, it was demon-
strated that UVR-induced immuno-
suppression is systemic and mediated
via antigen-specific regulatory T cells
(Tregs). These observations gave rise to
the hypothesis that the migration of
UVR-damaged but still viable LCs to
the regional lymph nodes is essential
for the induction of UVR Tregs (Schwarz
et al., 2005). In agreement, adoptive
transfer experiments with T cells
from UVR-exposed and LC-depleted
mice failed to suppress CHS in the
recipients, indicating that UVR Tregs
did not develop in the absence of LCs
(Schwarz et al., 2010). Taken together,
these data establish a critical role of LCs
in promoting photocarcinogenesis by
downmodulating adaptive immune
responses, which will have significant
impact to elucidate novel strategies to
prevent and treat skin cancers. In this
respect, IL-12 and IL-23 have been
shown to counteract photocarcino-
genesis by the induction of DNA repair
mechanisms, as well as inhibition of
Tregs (Schwarz and Schwarz, 2011;
Jantschitsch et al., 2012). An important
unresolved question for future
investigation remains whether IL-12/
IL-23 or IL-18 (Schwarz et al., 2006)
has the capacity to mitigate PAH-
induced skin cancer through the acti-
vation of the DNA repair machinery.
CYP1B1-independent and CYP1B1-UVR
synergistic pro-carcinogenic effects of LCs
An intriguing observation by Lewis
et al., (2014) is that LCs promote skin
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Figure 1. Regulation of skin carcinogenesis by Langerhans cells and dermal APC. Tumor cells are painted in red, normal keratinocytes in blue, and mutated
keratinocytes are depicted by their red nuclei. PAHs are illustrated by purple dots. CYP1B1, cytochrome P450 enzyme 1B1; DC, (dermal) dendritic cell; DMBADE,
DMBA-t-3,4-diol-1,2-epoxide; LC, Langerhans cell; PAH, polyaromatic hydrocarbons; Teff, effector T cell; Treg, regulatory T cell.
Table 1. Langerhans cells in cutaneous carcinogenesis - a double-edged sword
Tumor protective effects of epidermal Langerhans cells during
steady state
Tumor promoting effects of UVR- or carcinogen-damaged epidermal
Langerhans cells
Potential for immunogenic tumor antigen presentation Tolerogenic tumor antigen presentation (Tregs)
Induction of DNA repair mechanisms via IL-12/IL-23 Carcinogen metabolism and transfer to keratinocytes
Clinical Implications
 Polyaromatic hydrocarbons (PAHs) are relevant skin carcinogens.
 Langerhans cells (LCs) promote cutaneous carcinogenesis via PAH uptake,
metabolism, and transfer of mutagenic metabolites to adjacent
keratinocytes.
 Loss of immune surveillance and induction of regulatory T cells by DNA-
damaged LCs also contribute to skin cancer development and may act
synergistically with chemical carcinogens.
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carcinogenesis also by CYP1B1-
independent effects. On one hand,
tumors in CYP1B1 / LC recon-
stituted mice appeared 10 days earlier
than in LC-deficient animals. Moreover,
in the presence of CYP1B1 / LCs
DNA damage was significantly reduced
compared with LC-sufficient mice, but
the skin harbored more mutations as in
mice devoid of all LCs. One possible
explanation for these findings may be
that LCs express additional CYP enzymes
that contribute to the carcinogenic
metabolism of DMBA. For example,
LCs express CYP2E1, which is able to
activate several carcinogens (Saeki et al.,
2002). Although a comprehensive
analysis of their CYP enzyme profile
following activation is still missing.
Another interesting angle is the fact
that PAHs, including DMBA, can bind
to and activate the endogenous aryl
hydrocarbon receptor (AhR). The AhR
is expressed by virtually all cells present
in the skin, hence also by LCs, and
represents a transcription factor and
major sensor of environmental chemical
signals (Esser et al., 2013). In the
absence of a ligand, it resides in the
cytosol as an inactive complex with
several chaperones. Upon ligand bind-
ing, the AhR translocates to the nucleus,
where it is released from the complex
and induces the transcription of target
genes such as CYP1A1, CYP1B1, and
other CYP enzymes (Stockinger et al.,
2014). In this manner, the AhR may
directly influence the capacity of LCs to
generate mutagenic DMBA metabolites
and blocking AhR engagement on LCs
may have therapeutic potential (see also
below).
Beside its direct contribution to
chemical carcinogenesis (Matsumoto
et al., 2007), the AhR is activated by
UVR exposure and thus may also
be involved in photocarcinogenesis.
Although UVR activation of the AhR in
keratinocytes leads to the elevated
expression of CYP enzymes (Katiyar
et al., 2000; Fritsche et al., 2007), its
effect on CYP enzyme expression in LCs
remains unexplored. LCs in AhR-
deficient mice retain an immature
phenotype characterized by an
increased phagocytic capacity and a
failure to upregulate costimulatory
molecules because of diminished levels
of granulocyte macrophage-colony sti-
mulating factor in the absence of
dendritic epidermal T cells in AhR /
(Jux et al., 2009; Kadow et al., 2011).
Consequently, CHS responses are
impaired in AhR knockout mice.
Moreover, AhR-deficient LCs failed to
upregulate indoleamine 2,3-dioxygenase
(IDO) following Toll-like receptor
activation. LC tryptophan metabolism
may affect cutaneous carcinogenesis in
multiple ways. On one hand, by IDO-
mediated generation of kynurenines
associated with the suppression of T-cell
responses and induction of Tregs. On the
other hand, exposure of tryptophan
to UVR leads to the formation of
6-formylindolo [3,2-b]carbazole, a high-
affinity AhR ligand causing prolonged
AhR activation (Stockinger et al., 2014).
Finally, there is accumulating
evidence that PAHs and UVR exert
synergistic effects potentiating the carci-
nogenic properties of either agent alone.
Chronic exposure of mice to both
inhalation of PAH-containing tobacco
smoke and UVR triggers the outgrowth
of cutaneous SCC with a higher fre-
quency compared with either treatment
alone (Pavlou et al., 2009). Furthermore,
skin-painting of DMBA or mutagenic
benzo[a]pyrene before UVR signifi-
cantly enhances skin tumor formation
relative to UVR exposure alone (Berking
et al., 2002; Burke and Wei, 2009).
Further dissection of these complex
regulatory events and unraveling the
role and molecular control of LCs in
chemical and UVR-induced cutaneous
carcinogenesis warrant further analysis
of LC-specific AhR and CYP enzyme
knockout mice.
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